Models Used for Pharmacokinetic Evaluation of Nanoparticulate Drug Delivery Systems (NPDDS)

Chaurawal, Nishtha; Raza, Kaisar

doi:10.1007/978-3-030-83395-4_4

Cited by 1 publication

(1 citation statement)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There have been many different kinds of nanovehicles created, and many polysaccharide-based ones have been utilized to carry anticancer medications. Few of them might interrelate with membrane receptors [ 86 , 87 ]. To deliver MGF, specialized nanovehicles made of polysaccharides may be appropriate [ 16 ].…”

Section: Mangiferin: Challenges In the Clinical Translationmentioning

confidence: 99%

Nanotechnology-Based Drug Delivery Approaches of Mangiferin: Promises, Reality and Challenges in Cancer Chemotherapy

Sarfraz,

Khan,

Batiha

et al. 2023

Cancers

View full text Add to dashboard Cite

Mangiferin (MGF), a xanthone derived from Mangifera indica L., initially employed as a nutraceutical, is now being explored extensively for its anticancer potential. Scientists across the globe have explored this bioactive for managing a variety of cancers using validated in vitro and in vivo models. The in vitro anticancer potential of this biomolecule on well-established breast cancer cell lines such as MDA-MB-23, BEAS-2B cells and MCF-7 is closer to many approved synthetic anticancer agents. However, the solubility and bioavailability of this xanthone are the main challenges, and its oral bioavailability is reported to be less than 2%, and its aqueous solubility is also 0.111 mg/mL. Nano-drug delivery systems have attempted to deliver the drugs at the desired site at a desired rate in desired amounts. Many researchers have explored various nanotechnology-based approaches to provide effective and safe delivery of mangiferin for cancer therapy. Nanoparticles were used as carriers to encapsulate mangiferin, protecting it from degradation and facilitating its delivery to cancer cells. They have attempted to enhance the bioavailability, safety and efficacy of this very bioactive using drug delivery approaches. The present review focuses on the origin and structure elucidation of mangiferin and its derivatives and the benefits of this bioactive. The review also offers insight into the delivery-related challenges of mangiferin and its applications in nanosized forms against cancer. The use of a relatively new deep-learning approach to solve the pharmacokinetic issues of this bioactive has also been discussed. The review also critically analyzes the future hope for mangiferin as a therapeutic agent for cancer management.

show abstract

Section: Mangiferin: Challenges In the Clinical Translationmentioning

confidence: 99%